A cross-sectional analysis of symptom severity in adults with influenza and other acute respiratory illness in the outpatient setting

Jeffrey J VanWormer, Maria E Sundaram, Jennifer K Meece, Edward A Belongia, Jeffrey J VanWormer, Maria E Sundaram, Jennifer K Meece, Edward A Belongia

Abstract

Background: Acute respiratory infections (ARIs) are common in outpatient practice, and the severity of symptoms contributes to the overall burden of illness. We examined the association between a subjective symptom severity score, demographic and clinical characteristics, and presence of laboratory-confirmed influenza among central Wisconsin adults who sought care for ARI during four influenza seasons. We hypothesized that adults with laboratory-confirmed influenza would rate their symptoms as more severe relative to adults without influenza, and vaccinated adults with influenza would rate symptoms as less severe than those who were not vaccinated.

Methods: Patients with acute respiratory illness, including feverishness or cough symptoms ≤ 7 days duration, were prospectively enrolled and tested for influenza by reverse transcription polymerase chain reaction (RT-PCR) during influenza seasons 2007-08 through 2010-11. Perceived severity was self-rated during the enrollment interview for eight symptoms, on a scale of 0 (absent) to 3 (severe). Scores for each symptom were summed to generate a combined severity score ranging from 1 to 24 for each individual. The association between influenza test result and severity score was examined using linear regression.

Results: There were 2,374 individuals included in the analysis, including 324 with RT-PCR confirmed influenza. The mean symptom severity score was 12.3 (±4.1) points, and the most common symptoms were cough (92%), fatigue (91%), and nasal congestion (84%). In the final adjusted model, influenza infection was the strongest independent predictor of higher severity score, with a mean increase of 1.7 points compared to those who were influenza negative (p < 0.001). Among adults with influenza, the association between influenza vaccination and symptom severity was modified by age (p < 0.001). In adults ≥ 65 years old with RT-PCR confirmed influenza, symptom severity was 31% lower in those who were vaccinated as compared to those who were not vaccinated.

Conclusions: Influenza is associated with more severe symptoms of acute respiratory illness. The association between influenza vaccination and reduced symptom severity in older adults should be confirmed and explored further in other populations and seasons.

Figures

Figure 1
Figure 1
Number of participants who were influenza positive and negative by symptom severity score. The percentages above each bar correspond to the percent of participants who were influenza positive at each symptom severity score value.
Figure 2
Figure 2
Least-squares adjusted symptom severity scores, stratified by age group, influenza, and vaccination status (N = 2,374).

References

    1. Denny FW. The clinical impact of human respiratory virus infections. Am J Respir Crit Care Med. 1995;14:S4–S12. doi: 10.1164/ajrccm/152.4_Pt_2.S4.
    1. Heikkinen T, Jarvinen A. The common cold. Lancet. 2003;14:51–59. doi: 10.1016/S0140-6736(03)12162-9.
    1. Siston AM, Rasmussen SA, Honein MA, Fry AM, Seib K, Callaghan WM, Louie J, Doyle TJ, Crockett M, Lynfield R, Moore Z, Wiedeman C, Anand M, Tabony L, Nielsen CF, Waller K, Page S, Thompson JM, Avery C, Springs CB, Jones T, Williams JL, Newsome K, Finelli L, Jamieson DJ. Pandemic H1N1 Influenza in Pregnancy Working Group. Pandemic 2009 influenza A(H1N1) virus illness among pregnant women in the United States. JAMA. 2010;14(15):1517–1525. doi: 10.1001/jama.2010.479.
    1. Varner MW, Rice MM, Anderson B, Tolosa JE, Sheffield J, Spong CY, Saade G, Peaceman AM, Louis JM, Wapner RJ, Tita AT, Sorokin Y, Blackwell SC, Prasad M, Thorp JM Jr, Naresh A, Van Dorsten JP. Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) Maternal-Fetal Medicine Units Network (MFMU) Influenza-like illness in hospitalized pregnant and postpartum women during the 2009–2010 H1N1 pandemic. Obstet Gynecol. 2011;14(3):593–600. doi: 10.1097/AOG.0b013e318229e484.
    1. Kumar D, Michaels MG, Morris MI, Green M, Avery RK, Liu C, Danziger-Isakov L, Stosor V, Estabrook M, Gantt S, Marr KA, Martin S, Silveira FP, Razonable RR, Allen UD, Levi ME, Lyon GM, Bell LE, Huprikar S, Patel G, Gregg KS, Pursell K, Helmersen D, Julian KG, Shiley K, Bono B, Dharnidharka VR, Alavi G, Kalpoe JS, Shoham S. et al.Outcomes from pandemic influenza A H1N1 infection in recipients of solid-organ transplants: a multicentre cohort study. Lancet Infect Dis. 2010;14:521–526. doi: 10.1016/S1473-3099(10)70133-X.
    1. Centers for Disease Control and Prevention (CDC) 2009 pandemic influenza A (H1N1) in pregnant women requiring intensive care – New York City, 2009. Morb Mortal Wkly Rep. 2010;14(11):321–326.
    1. Creanga AA, Johnson TF, Graitcer SB, Hartman LK, Al-Samarrai T, Schwarz AG, Chu SY, Sackoff JE, Jamieson DJ, Fine AD, Shapiro-Mendoza CK, Jones LE, Uyeki TM, Balter S, Bish CL, Finelli L, Honein MA. Severity of 2009 pandemic influenza A (H1N1) virus infection in pregnant women. Obstet Gynecol. 2010;14:717–726. doi: 10.1097/AOG.0b013e3181d57947.
    1. Schanzer DL, Schwartz B. Impact of seasonal and pandemic influenza on emergency department visits, 2003–2010, Ontari, Canada. Acad Emerg Med. 2013;14(4):388–397. doi: 10.1111/acem.12111.
    1. Denholm JT, Gordon CL, Johnson PD, Hewagama SS, Stuart RL, Aboltins C, Jeremiah C, Knox J, Lane GP, Tramontana AR, Slavin MA, Schulz TR, Richards M, Birch CJ, Cheng AC. Hospitalised adult patients with pandemic (H1N1) 2009 influenza in Melbourne, Australia. Med J Aust. 2010;14:84–86.
    1. Centers for Disease Control and Prevention (CDC) Patients hospitalized with 2009 pandemic influenza A (H1N1) – New York City, May 2009. Morb Mortal Wkly Rep. 2010;14(51 & 52):1436–1440.
    1. Widmer K, Zhu Y, Williams JV, Griffin MR, Edwards KM, Talbot HK. Rates of hospitalizations for respiratory syncytial virus, human metapneumovirus, and influenza virus in older adults. J Infect Dis. 2012;14(1):56–62. doi: 10.1093/infdis/jis309.
    1. Elliot AJ, Cross KW, Fleming DM. Acute respiratory infections and winter pressures on hospital admissions in England and Wales 1990–2005. J Public Health (Oxf) 2008;14(1):91–98. doi: 10.1093/pubmed/fdn003.
    1. Chien YS, Su CP, Tsai HT, Huang AS, Lien CE, Hung MN, Chuang JH, Kuo HS, Chang SC. Predictors and outcomes of respiratory failure among hospitalized pneumonia patients with 2009 H1N1 influenza in Taiwan. J Infect. 2010;14(2):168–174. doi: 10.1016/j.jinf.2009.12.012.
    1. Gran JM, Kacelnik O, Grjibovxki AM, Aavitsland P, Iversen BG. Counting pandemic deaths: comparing reported numbers of deaths from influenza A(H1N1) pdm09 with estimated excess mortality. Influenza Other Respi Viruses. 2013. [Epub ahead of print]
    1. Fowlkes A, Dasgupta S, Chao E, Lemmings J, Goodin K, Harris M, Martin K, Feist M, Wu W, Boulton R, Temte J, Brammer L, Finelli L. Estimating influenza incidence and rates of influenza-like illness in the outpatient setting. Influenza Other Respi Viruses. 2012. Epub ahead of print.
    1. Li S, Leader S. Economic burden and absenteeism from influenza-like illness in healthy households with children (5–17 years) in the US. Respir Med. 2007;14(6):1244–1250. doi: 10.1016/j.rmed.2006.10.022.
    1. Molinari NA, Ortega-Sanchez IR, Messonnier ML, Thompson WW, Wortley PM, Weintraub E, Bridges CB. The annual impact of seasonal influenza in the US: measuring disease burden and costs. Vaccine. 2007;14(27):5086–5096. doi: 10.1016/j.vaccine.2007.03.046.
    1. Belongia EA, Irving SA, Waring SC, Coleman LA, Meece JK, Vandermause M, LIndstrom S, Kempf D, Shay DK. Clinical characteristics and 30-day outcomes for influenza A 2009 (H1N1), 2008–2009 (H1N1), and 2007–2008 (H3N2) infections. JAMA. 2010;14(10):1091–1098. doi: 10.1001/jama.2010.1277.
    1. Sauro A, Barone F, Blasio G, Russo L, Santillo L. Do influenza and acute respiratory infective diseases weigh heavily on general practitioners’ daily practice? Eur J Gen Pract. 2006;14(1):34–36. doi: 10.1080/13814780600757153.
    1. Wilkinson TM, Li CK, Chui CS, Huang AK, Perkins M, Liebner JC, Lambkin-Williams R, Gilbert A, Oxford J, Nicholas B, Staples KJ, Dong T, Douek DC, McMichael AJ, Xu XN. Preexisting influenza-specific CD4+ T cells correlate with disease protection against influenza challenge in humans. Nat Med. 2012;14(2):274–280. doi: 10.1038/nm.2612.
    1. Castilla J, Godoy P, Dominguez A, Martinez-Baz I, Astray J, Martin V, Delgado-Rodriguez M, Baricot M, Soldevila N, Mayoral JM, Quintana JM, Galán JC, Castro A, González-Candelas F, Garín O, Saez M, Tamames S, Pumarola T. CIBERESP Cases and Controls in Influenza Working Group Spain. Influenza vaccine effectiveness in preventing outpatient, inpatient, and severe cases of laboratory-confirmed influenza. Clin Infect Dis. 2013;14(2):167–175. doi: 10.1093/cid/cit194.
    1. Turner RB. Epidemiology, pathogenesis, and treatment of the common cold. Ann Allergy Asthma Immunol. 1997;14:531–539. doi: 10.1016/S1081-1206(10)63213-9.
    1. Belongia EA, Kieke BA, Donahue JG, Coleman LA, Irving SA, Meece JK, Vandermause M, Lindstrom S, Gargiullo P, Shay DK. Influenza vaccine effectiveness in Wisconsin during the 2007–08 season: comparison of interim and final results. Vaccine. 2011;14(38):6558–6563. doi: 10.1016/j.vaccine.2011.07.002.
    1. Hernes SS, Quarsten H, Hagen E, Lyngroth AL, Pripp AH, Bjorvatn B, Bakke PS. Swabbing for respiratory viral infections in older patients: a comparison of rayon and nylon flocked swabs. Eur J Clin Microbiol Infect Dis. 2011;14(2):159–165. doi: 10.1007/s10096-010-1064-2.
    1. Centers for Disease Control and Prevention NCfIaRD. Evaluation of rapid influenza diagnostic tests for detection of novel influenza A (H1N1) virus - United States, 2009. Morb Mortal Wkly Rep. 2009;14:826–829.
    1. Irving SA, Donahue JG, Shay DK, Ellis-Coyle TL, Belongia EA. Evaluation of self-reported and registry-based influenza vaccination status in a Wisconsin cohort. Vaccine. 2009;14(47):6546–6549. doi: 10.1016/j.vaccine.2009.08.050.
    1. Cody RP, Smith JK. Applied Statistics and the SAS Programming Language. New York, NY: Prentice Hall; 2005.
    1. Murasko DM, Bernstein ED, Gardner EM, Gross P, Munk G, Dran S, Abrutyn E. Role of humoral and cell-mediated immunity in protection from influenza disease after immunization of healthy elderly. Exp Gerontol. 2002;14(2–3):427–439.
    1. Zhou X, McElhaney JE. Age-related changes in memory and effector T cells responding to influenza A/H3N2 and pandemic A/H1N1 strains in humans. Vaccine. 2011;14(11):2169–2177. doi: 10.1016/j.vaccine.2010.12.029.
    1. Jackson GG, Dowling HF, Anderson TO, Riff L, Saporta J, Turck M. Susceptibility and immunity to common upper respiratory viral infections: the common cold. Ann Intern Med. 1960;14:719–738.
    1. Farr BM, Gwaltney JM, Hendley JO, Hayden FG, Naclerio RM, McBride T, Doyle WJ, Sorrentino JV, Riker DK, Proud D. A randomized controlled trial of glucocorticoid prophylaxis against experimental rhinovirus infection. J Infect Dis. 1990;14(5):1173–1177. doi: 10.1093/infdis/162.5.1173.
    1. Hayden FG, Treanor JJ, Betts RF, Lobo M, Esinhart JD, Hussey EK. Safety and efficacy of the neuraminidase inhibitor GG167 in experimental human influenza. JAMA. 1996;14(4):295–299. doi: 10.1001/jama.1996.03530280047035.
    1. MIST (Management of Influenza in the Southern Hemisphere Trialists) Study Group. Randomised trial of efficacy and safety of inhaled zanamivir in treatment of influenza A and B virus infections. From the MIST (Management of Influenza in the Southern Hemisphere Trialists) Study Group. Lancet. 1998;14(9144):1877–1881.
    1. Prasad AS, Fitzgerald JT, Bao B, Beck FW, Chandrasekar PH. Duration of symptoms and plasma cytokine levels in patients with the common cold treated with zinc acetate. A randomized, double-blind, placebo-controlled trial. Ann Intern Med. 2000;14(4):245–252.
    1. Nicholson KG, Aoki FY, Osterhaus ADM, Trottier S, Carewicz O, Mercier CH, Rode A, Kinnersley N, Ward P. Efficacy and safety of oseltamivir in treatment of acute influenza: a randomised controlled trial. Lancet. 2000;14:1845–1850. doi: 10.1016/S0140-6736(00)02288-1.
    1. Predy GN, Goel V, Lovlin R, Donner A, Stitt L, Basu TK. Efficacy of an extract of North American ginseng containing poly-furanosyl-pyranosyl-saccharides for preventing upper respiratory tract infections: a randomized controlled trial. CMAJ. 2005;14(9):1043–1048. doi: 10.1503/cmaj.1041470.
    1. Pach D, Knochel B, Ludtke R, Wruck K, Willich SN, Witt CM. Visiting a sauna: does inhaling hot dry air reduce common cold symptoms? A randomised controlled trial. Med J Aust. 2010;14:730–734.
    1. Barrett B, Locken K, Maberry R, Schwamman J, Brown R, Bobula J, Stauffacher EA. The Wisconsin Upper Respiratory Symptom Survey (WURSS): a new research instrument for assessing the common cold. J Fam Pract. 2002;14(3):265.
    1. Pronk NP, Crain AL, Vanwormer JJ, Martinson BC, Boucher JL, Cosentino DL. The use of telehealth technology in assessing the accuracy of self-reported weight and the impact of a daily immediate-feedback intervention among obese employees. Int J Telemed Appl. 2011;14:909248.

Source: PubMed

Sponsor e collaboratori

Condizioni mediche

Interventi farmacologici

3
Sottoscrivi